Orchard Therapeutics Announces U.S. FDA Clearance of IND Application for OTL-203 in MPS-IH
Global registrational trial expected to commence in the second half of 2023BOSTON and LONDON, Jan. 05, 2023 -- Orchard Therapeutics , a global gene therapy leader, today announced the U.S. Food and... | January 5, 2023
Source: marketscreener.com